Khanani AM, Patel SS, Staurenghi G, Tadayoni R, et al. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial. Lancet 2023;402:1449-1458.
PMID: 37696275